Celadon

5stories

10 Jullast updated

Cannabis Exodus from Public Markets Continues: Celadon Announces Plans to Leave AIM and IMC Fights to Remain on NASDAQ

The exodus of listed cannabis companies from the public markets, particularly in the UK, is continuing at pace as yet another medical cannabis operator has announced plans to delist.

Ben Stevens10 July 2025

Markets & Stocks

Akanda Implements 2nd Stock Split Amid Debt Woes, DanCann Pharma Earnings Fall Due to Strategy Change, & More From Celadon

23 May 2024

Markets & Stocks

Celadon Announces New £1.2m Supply Deal, Intercure Continues Record Run, & Chill Brands Launches Products in UK

7 September 2023

Medical

UK Medical Cannabis Industry Gathers Momentum Amid Numerous Research Milestones

2 August 2023

More in Celadon

Pharmaceutical
Summerway Capital Returns To AIM To Fund £80m Take-Over Of UK Cannabis Cultivator
SUMMERWAY Capital’s (LON: SWC) £80m reverse takeover of one of the UK’s few licenced high-THC cannabis growers has seen it relaunch its shares on the London Stock Exchange (LSE) in order to fund its new acquisition.
Ben Stevens1 Mar

Sections

Data & Trackers

What’s On

More